AptaBio Therapeutics
Latest round
- Series B
Last raised
- Jun 2016
Total raised
- $12M
Investors
- 7
About AptaBio Therapeutics
Based in Gyeonggi-do, South Korea, and founded in 2009, AptaBio Therapeutics Inc. operates as a pharmaceutical bio company providing drugs that help in the treatment of vascular disorders, neurological diseases, diabetic complications, and intractable cancers using immunotherapy. In August 2023, AptaBio Therapeutics Inc.S. AptaBio Therapeutics Inc. provides support life science product development through Platform technology. The company developed a variety of drugs for medical and healthcare industry such as Lipofector-EXT, Lipofector-2000, Lipofector-NO, and Lipofector-pMAX, and many more. In addition, the company specializes in medical and pharmaceutical clinical research and their trials. AptaBio Therapeutics Inc. provides its research in disease such as diabetes, covid-19, Muscular degeneration, brain disease, and pancreatic cancer.
Who invested in AptaBio Therapeutics
7 investors across 2 rounds
See all investors in AptaBio Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AptaBio Therapeutics
Who invested in AptaBio Therapeutics?
AptaBio Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AptaBio Therapeutics raised?
AptaBio Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AptaBio Therapeutics last raise money?
AptaBio Therapeutics's most recent round on record is a Series B, in Jun 2016.
What does AptaBio Therapeutics do?
Based in Gyeonggi-do, South Korea, and founded in 2009, AptaBio Therapeutics Inc.
Where is AptaBio Therapeutics headquartered?
AptaBio Therapeutics is headquartered in Gyeonggi-do, South Korea.
Which VCs invest in companies like AptaBio Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at AptaBio Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like AptaBio Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.